Sundaravel Ananthavel

Sundaravel Ananthavel PhD is an accomplished executive with extensive experience in the pharmaceutical and biotechnology industries, currently serving as Executive Director at AN2 Therapeutics since June 2021. Previously held significant roles including Senior Director at AcelRx Pharmaceuticals, where comprehensive quality systems were developed for clinical and commercial operations, and Associate Director of Quality at Intarcia Therapeutics, overseeing quality for drug/device combination products. Early career positions include Senior Manager of Quality at Anacor Pharmaceuticals and Principal Scientist/Manager at Novartis, highlighting a strong focus on quality assurance and compliance throughout various stages of product development. Sundaravel's academic credentials include a PhD in Chemistry from the Indian Institute of Science (IISc) and a Master's degree in Chemistry from the American College.